Skip to main content

Table 3 Immunosuppressive condition associated with Pneumocystis pneumonia in patients who were not infected with HIV (n = 27)

From: Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection

Renal transplant, number

10

Chronic inflammatory disease, number

6

   Rheumatoid arthritis, number

3

   Dermatomyositis, number

1

   Wegener disease, number

1

   Temporal arteritis, number

1

Solid tumor, number

4

Hematologic malignant disorder, number

4

   Chronic lymphoid leukemia, number

1

   Acute lymphoid leukemia, number

1

   Non-Hodgkin lymphoma, number

2

Lung fibrosis, number

2

Alcoholic hepatitis, number

1

Previous corticosteroid therapy, number

26

   Duration at the time of admission, months

10 (1–144)

   Daily dose, mg prednisone equivalent

13 (5–240)

   Patients with a daily dose of ≤ 15 mg prednisone equivalent, number

13

Other immunosuppressive therapy, number

23

   Methotrexate, number

7

   Mycophenolate mofetil, number

6

   Tacrolimus, number

5

   Cyclosporine, number

2

   Cyclophosphamide, number

2

   Azathioprine, number

1

   Other cancer chemotherapy, number

4

Neutrophil count, cells per microliter

670 (1,160–22,200)

Lymphocyte counta, cells per microliter

730 (130–3,090)

  1. Values are expressed as median (range) or as absolute value. aThe lymphocyte count is reported on 24 patients after excluding 3 patients with lymphoid leukemia. The neutrophil count is reported on the whole population of HIV-negative patients (n = 27).